or locoregionally advanced metastatic stage IIIB/C or stage IV M1a melanoma in the subgroup with tumors accessible for direct injection are candidates for new incarnations of intralesional therapy.

The differential diagnosis included hematoma formation, a cyanosis-like reaction, trauma from the intralesional injection, or a compartment syndrome-type reaction to the CA antigen. The purple hue ...